COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Diego Ripamonti
Institution
Infectious Diseases Unit - ASST Papa Giovanni XXIII
Address
Bergamo
Italy
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2001
1
2002
3
2003
5
2004
5
2005
1
2006
2
2007
4
2008
3
2009
1
2010
2
2011
2
2012
1
2013
1
2014
5
2015
1
2016
4
2017
3
2018
2
2020
3
2021
3
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Gritti G
,
Raimondi F
,
Bottazzi B
,
Ripamonti D
,
Riva I
,
Landi F
,
Alborghetti L
,
Frigeni M
,
Damiani M
,
Micò C
,
Fagiuoli S
,
Lorini FL
,
Gandini L
,
Novelli L
,
Morgan JP
,
Owens BMJ
,
Kanhai KJK
,
Reljanovic GT
,
Rizzi M
,
Di Marco F
,
Mantovani A
,
Rambaldi A
. Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 Sep; 35(9):2734.
PMID:
34183767
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Olender SA
,
Walunas TL
, Martinez E,
Perez KK
,
Castagna A
,
Wang S
,
Kurbegov D
,
Goyal P
,
Ripamonti D
,
Balani B
,
De Rosa FG
,
De Wit S
,
Kim SW
,
Diaz G
,
Bruno R
,
Mullane KM
,
Lye DC
,
Gottlieb RL
,
Haubrich RH
,
Chokkalingam AP
,
Wu G
,
Diaz-Cuervo H
,
Brainard DM
,
Lee IH
,
Hu H
,
Lin L
,
Osinusi AO
,
Bernardino JI
,
Boffito M
. Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality. Open Forum Infect Dis. 2021 Jul; 8(7):ofab278.
PMID:
34282406
.
Citations:
1
Gritti G
,
Raimondi F
,
Bottazzi B
,
Ripamonti D
,
Riva I
,
Landi F
,
Alborghetti L
,
Frigeni M
,
Damiani M
,
Micò C
,
Fagiuoli S
,
Lorini FL
,
Gandini L
,
Novelli L
,
Morgan JP
,
Owens BMJ
,
Kanhai KJK
,
Reljanovic GT
,
Rizzi M
,
Di Marco F
,
Mantovani A
,
Rambaldi A
. Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 09; 35(9):2710-2714.
PMID:
34031531
.
Citations:
5
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Perrone F
,
Piccirillo MC
,
Ascierto PA
,
Salvarani C
,
Parrella R
,
Marata AM
,
Popoli P
,
Ferraris L
,
Marrocco-Trischitta MM
,
Ripamonti D
,
Binda F
,
Bonfanti P
,
Squillace N
,
Castelli F
,
Muiesan ML
,
Lichtner M
,
Calzetti C
,
Salerno ND
,
Atripaldi L
,
Cascella M
,
Costantini M
,
Dolci G
,
Facciolongo NC
,
Fraganza F
,
Massari M
,
Montesarchio V
,
Mussini C
,
Negri EA
,
Botti G
,
Cardone C
,
Gargiulo P
,
Gravina A
,
Schettino C
,
Arenare L
,
Chiodini P
,
Gallo C
. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020 10 21; 18(1):405.
PMID:
33087150
.
Citations:
29
Fields:
Med
Medicine (General)
Translation:
Humans
Cells
PH
Public Health
CT
Clinical Trials
Maggiolo F
,
Zoboli F
,
Arosio M
,
Valenti D
,
Guarneri D
,
Sangiorgio L
,
Ripamonti D
,
Callegaro A
. SARS-CoV-2 infection in persons living with HIV: A single center prospective cohort. J Med Virol. 2021 02; 93(2):1145-1149.
PMID:
32706409
.
Citations:
13
Fields:
Vir
Virology
Translation:
Humans
Cells
Greco G
,
Ripamonti D
,
Binda F
,
Fabretti F
,
Grazioli L
,
Rizzi M
. Potential role of subcutaneous tocilizumab injections in patients with COVID-19 associated pneumonia. J Med Virol. 2021 02; 93(2):686-688.
PMID:
32897539
.
Citations:
Fields:
Vir
Virology
Translation:
Humans
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs